Invention Application
- Patent Title: PHARMACEUTICAL COMPOSITIONS COMPRISING INSULIN SENSITIZER AND INSULIN SECRETAGOGUE
-
Application No.: PCT/US2009/038365Application Date: 2009-03-26
-
Publication No.: WO2009120844A3Publication Date: 2009-10-01
- Inventor: KANARI, Itamar , LIEBOVICI, Minutza , FOX, Michael
- Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD. , TEVA PHARMACEUTICALS USA, INC. , KANARI, Itamar , LIEBOVICI, Minutza , FOX, Michael
- Applicant Address: 5 Basel Street P.O. Box 3190 49131 Petah-Tiqva IL
- Assignee: TEVA PHARMACEUTICAL INDUSTRIES LTD.,TEVA PHARMACEUTICALS USA, INC.,KANARI, Itamar,LIEBOVICI, Minutza,FOX, Michael
- Current Assignee: TEVA PHARMACEUTICAL INDUSTRIES LTD.,TEVA PHARMACEUTICALS USA, INC.,KANARI, Itamar,LIEBOVICI, Minutza,FOX, Michael
- Current Assignee Address: 5 Basel Street P.O. Box 3190 49131 Petah-Tiqva IL
- Agency: WALLACE, David, W.
- Priority: US61/039,691 20080326
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/50 ; A61K31/00 ; A61K31/4439 ; A61K31/64
Abstract:
Dosage forms containing an insulin sensitizer, such as pioglitazone, and an insulin secretogogue, such as glimepiride, are described. Including a cellulose derivative in the dosage form increased the dissolution rate of the insulin sensitizer and/or the insulin secretagogue.
Information query
